El-Awady Mohamed I, El-Brashy Amina M, Abdallah Nora A, Ibrahim Fawzia A
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Delta University for Science and Technology, International Coastal Road, Gamasa 11152, Egypt.
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Jul 5;295:122573. doi: 10.1016/j.saa.2023.122573. Epub 2023 Mar 4.
Four accurate, green, uncomplicated, and fast spectrophotometric procedures were established for the purpose of resolving as well as quantifying a ternary combination prescribed for cardiovascular patients, such as aspirin, atorvastatin, and ramipril. Method (A) is based on the first derivative zero-crossing spectrophotometry for the determination of aspirin and atorvastatin at 247.4 nm and 302.6 nm, respectively. Ramipril was determined using the second derivative at 211 nm. Method (B) depends on the ratio spectra first derivative (RDS) where the absorption spectrum of the ternary combination was divided by the spectrum of one of the analytes. When treated similarly, the concentrations of the other two analytes were measured using their corresponding calibration graphs. For the determination of ASP and RAM, ATR was used as a divisor with a concentration of 26 µg/mL, and the RDS values at 272.0 and 225.8 nm, respectively, were plotted against the ASP and RAM concentrations. Using 40 µg/mL ASP as a divisor, ATR was analyzed, and the RDS values at 295 nm were plotted versus the ATR concentration. Method (C) is based on the double divisor-ratio spectra derivative technique. In this technique, the derivative of the ratio spectrum is computed by dividing the absorption spectra of the studied combination by the standard spectrum of abinary combination of two of the three analytes being studied. The concentrations of the three analytes in the mixture were assayed by determining the absorbance either at the positive or the negative amplitude. For the determination of ASP, ATR, and RAM, the wavelengths used were 244, 295, and 220 nm, respectively. Method (D) was a hybrid double divisor-ratio spectra technique based on convolving the double divisor-ratio spectra with trigonometric Fourier functions. The magnitudes of the Fourier function coefficients at either maximum or minimum points were correlated to the concentration of each drug in the mixture. The specificity of the suggested methods was tested by analyzing synthetic laboratory-prepared combinations and laboratory-made tablets. Furthermore, the accuracy and precision were ensured by statistically comparing the obtained results with those obtained from comparison method using Bartlett's Test for Equality of Variances and ANOVA test.
为了解析并定量针对心血管疾病患者开具的由阿司匹林、阿托伐他汀和雷米普利组成的三元组合药物,建立了四种准确、绿色、简便且快速的分光光度法。方法(A)基于一阶导数零交叉分光光度法,分别在247.4nm和302.6nm处测定阿司匹林和阿托伐他汀。雷米普利则在211nm处使用二阶导数进行测定。方法(B)依赖于比率光谱一阶导数(RDS),即将三元组合的吸收光谱除以其中一种分析物的光谱。经类似处理后,利用相应的校准曲线测量其他两种分析物的浓度。在测定阿司匹林(ASP)和雷米普利(RAM)时,使用浓度为26μg/mL的阿托伐他汀(ATR)作为除数,分别在272.0nm和225.8nm处的RDS值与ASP和RAM的浓度作图。以40μg/mL的ASP作为除数分析ATR,并将295nm处的RDS值与ATR浓度作图。方法(C)基于双除数比率光谱导数技术。在此技术中,通过将所研究组合的吸收光谱除以所研究的三种分析物中两种的二元组合的标准光谱来计算比率光谱的导数。通过在正振幅或负振幅处测定吸光度来分析混合物中三种分析物的浓度。在测定ASP、ATR和RAM时,使用的波长分别为244nm、295nm和220nm。方法(D)是一种基于将双除数比率光谱与三角傅里叶函数进行卷积的混合双除数比率光谱技术。在最大值或最小值点处的傅里叶函数系数的大小与混合物中每种药物的浓度相关。通过分析合成的实验室制备组合和实验室自制片剂来测试所建议方法的特异性。此外,通过使用Bartlett方差齐性检验和方差分析测试将所得结果与比较方法所得结果进行统计学比较,确保了准确性和精密度。